|
|
|
|
Manual approaches to Quality by Design (QbD) are increasingly outpaced by the demands of modern drug development. Gain insight into how intelligent, digital frameworks are helping CMC teams improve quality, accelerate submissions, and meet rising regulatory expectations.
|
|
|
|
|
Learn about ICH Q8, Q9, Q10, Q11, and Q14, which emphasize principles related to pharmaceutical development within the QbD framework, analytical procedure development, and risk management. Further, explore how data and digitalization can enhance development.
|
|
|
|
|
Manual workflows in Chemistry, Manufacturing, and Controls (CMC) development often lead to delays, data silos, and compliance challenges that can jeopardize regulatory readiness. Discover how digitization can eliminate bottlenecks, improve traceability, and accelerate timelines.
|
|
|
|
|
|
|
|
|
